Comments
Transcript
The PMDA convenes the second Science Board meeting
独立行政法人 医薬品医療機器総合機構 Pharmaceuticals and Medical Devices Agency Press Release For immediate Release: July 27, 2012 Media Inquiries: Toshiyoshi Tominaga, +81-3-3506-9456 Title: Convenes the second Science Board meeting The PMDA convenes the second Science Board meeting ~ Enhancing the review system in response to the Medical Innovations ~ While PMDA has been making various efforts to make its review process faster and more efficient by increasing the number of reviewers and revamping its review system, it is increasingly required to evaluate products using advanced science and technologies precisely and to provide sound advice and guidance. Under this circumstance, PMDA has been creating a system which ensures constant upskilling of its reviewers enabling them to assess the fruits of advanced technologies in close collaboration with academia that conducts cutting-edge scientific researches. As a part of its effort, PMDA established the Science Board as a high-level organ to give scientific advice. The Board consists of external experts who are active in the front lines of dental, pharmaceutical, and engineering fields. The second Science Board meeting will be held on July 31 (please refer to the Annex 1 for the list of the Science Board Members, Annex 2 for PMDA organization chart, and Annex 3 for List of the Office of Review Innovation Members.) The second meeting will discuss appointments of the members of the sub-committees dealing with pharmaceuticals, medical devices, biologics, and cellular- and tissue- based products (regenerative medicinal products). The agenda for the future discussion will be also discussed. Meeting is closed to public, since specific contents of individual approved products may be referred to. However, a briefing session by the Office of Review Innovation, with the chair of the Board, is scheduled after the meeting as below. Briefing session Place: PMDA 6th Floor, Meeting Room #8-9 Time and Date: Tuesday, July 31, 2012, 2:15 p.m. – 3:00 p.m. 独立行政法人 医薬品医療機器総合機構 Pharmaceuticals and Medical Devices Agency Press Release Annex 1 List of the Science Board Members (in the Japanese alphabetical order) Akinori Akaike Professor, Graduate School of Pharmaceutical Sciences, Nagoya University Tatsuro Irimura Professor, Graduate School of Pharmaceutical Sciences, the University of Tokyo Yukihide Iwamoto Professor, Orthopaedic Surgery, Department of Clinical Medicine, Kyushu University Hideyuki Okano Professor, Department of Physiology, Graduate School of Medicine, Keio University Chieko Kai Professor, Institute of Medical Science, the University of Tokyo Hideo Kusuoka Director General, Osaka National Hospital, National Hospital Organization Hideo Saji Professor, Graduate School of Pharmaceutical Sciences, Kyoto University Toshiya Sato Professor, Biostatistics, Public Health, Graduate School of Medicine, Kyoto University Yuichi Sugiyama Invited Senior Scientist, Sugiyama Laboratory, RIKEN Innovation Center, RIKEN Tatsutoshi Nakahata Deputy Director, Center for iPS Cell Research and Application, Kyoto University 独立行政法人 医薬品医療機器総合機構 Pharmaceuticals and Medical Devices Agency Press Release Masahiro Hayashi Director, Department of Pharmacy, Toranomon Hospital Akira Matsuda Professor, Faculty of Pharmaceutical Sciences, Hokkaido University Yoichiro Matsumoto Professor, Graduate School of Engineering, the University of Tokyo Masaki Mori Professor, Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University Nobuhiro Yamada President, University of Tsukuba Kazuhiko Yamamoto Professor, Graduate School of Medicine, the University of Tokyo Teruko Yamamoto Professor, Graduate School of Dentistry, Tohoku University Organization Chart of PMDA Secretariat Director Associate Deputy Director Associate General Director General Associate Executive Director as of July 2012 Annex 2 Office of Regulatory Science Office of Review Administration Associate Exectuive Director Office of Review Management Office of Standards and GLs Development Director (Center For Product Evaluation) Science Board Special Assistant Director General Office of Review Innovation Executive Director Office of International Programs Associate Center Director International Liaison Officers Office of New Drug Ⅰ-Ⅴ Associate Executive Director Office of Biologics Ⅰ,Ⅱ Office of OTC/Generic Drugs Associate Center Director Office of Medical Devices Ⅰ-Ⅲ Office of Conformity Audit Principal Senior Scientists, Senior Scientists Information Technology Promotion Group Chief Safety Officer Office of Safety Ⅰ, Ⅱ Office of GMP/QMS Inspection Executive Director Audit Office for Medical Devices Auditor Deputy Center Director Senior Executive Director for cellular and Tissue-based Products Auditor Deputy Center Director Chief Executive Chief Actuary Chief Relief Officer Office of Relief Funds Office of General Affairs Chief Management Officer Office of Financial Management Office of Planning and Coordination 独立行政法人 医薬品医療機器総合機構 Pharmaceuticals and Medical Devices Agency Press Release Annex 3 List of the Office of Review Innovation Members Director General Dr. Hideo Utsumi, Executive Director, PMDA Associate Director General Dr. Takao Yamori, Director of Center for Product Evaluation, PMDA Deputy Associate Director General Dr. Akihiro Umezawa, Deputy Center Director (for Cellular and Tissue-based Products), PMDA Deputy Associate Director General Dr. Ichiro Sakuma, Deputy Center Director (for Medical Devices), PMDA Secretariat Director Dr. Soichiro Isobe, Office Director, Office of Review Management, PMDA Deputy Secretariat Director Mr. Masakatsu Imoto, Review Director, Office of Medical Devices III, PMDA 独立行政法人 医薬品医療機器総合機構 Pharmaceuticals and Medical Devices Agency Press Release (Reference) Pharmaceuticals and Medical Devices Agency 〒100-0013 Shin-Kasumigaseki Bldg., 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo TEL: 03-3506-9407(Office of Review Innovation) FAX: 03-3506-9461 <Place> Briefing Session: 6th floor conference Room#8&9 14:15~15:00 Kasumigaseki Station (Chiyoda L・Marunouchi L・Hibiya L) Ext #A13, 8 minutes’ walk 【Map】 Kokkai-gijido-mae Station (Chiyoda L・Marunouchi L) Exit #3, 5 minutes’ walk Tameike-sanno Station (Ginza L・ Nanboku L) Exit #8, 7 minutes’ walk Toranomon Station (Ginza L) Exit #6, 5 minutes’ walk URL:ttp://www.pmda.go.jp/ 独立行政法人 医薬品医療機器総合機構 Pharmaceuticals and Medical Devices Agency 【Shin-Kasumigaseki Building 6th Floor】 Conference rooms #6-9 RECEPTION 低層エレベータ Conference rooms #1-5 Press Release